Brief: JW Cayman Therapeutics Posts FY Loss Attributable Of RMB1.66 Billion
March 26 (Reuters) - JW Cayman Therapeutics Co Ltd
2126.HK :
* FY LOSS ATTRIBUTABLE RMB1.66 BILLION VERSUS LOSS OF
RMB633.3
MILLION
Source text for Eikon: urn:newsml:reuters.com:*:nHKS1TrhMp
Further company coverage: 2126.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on JW (Cayman) Therapeutics Co
See all newsChina pharma industry not impacted by Beijing scrutiny of sensitive tech deals, JW chief says
Brief: JW (Cayman) Therapeutics Appoints Tian Feng As CEO, Executive Director
Australia's Imugene gains on alliance with JW Therapeutics for tumour treatment
Brief: JW (Cayman) Therapeutics H1 Net Income RMB -267.3 Million
Brief: JW (Cayman) Therapeutics Grants Juno Therapeutics Non-Exclusive License